| NCT ID | NCT05036850 |
| Status | Recruiting |
| Phase | — |
| Sponsor | George (Beijing) Clinical Research Co. Ltd. |
| Condition | Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2021-09-27 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2021-09-27 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.
Eligibility Criteria
Inclusion Criteria: 1. Documented diagnosis of primary kidney disease 2. Regular visits (at least 6 monthly) with a physician at a participating site 3. eGFR \> 15 ml/min/1.73 m2 4. ≥ 2 years of age 5. Willing and able to sign informed consent 6. Willing to be approached about participation in interventional research studies Exclusion Criteria: * 1\. Life-expectancy of less than 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05036850 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, studying Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05036850 currently recruiting?
Yes, NCT05036850 is actively recruiting participants. Contact the research team at CKPTN@georgeclinical.com for enrollment information.
Where is the NCT05036850 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05036850 clinical trial?
NCT05036850 is sponsored by George (Beijing) Clinical Research Co. Ltd.. The trial plans to enroll 1,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.